Today: 16 October 2025
11 February 2021
2 mins read

WHO backs AstraZeneca vaccine use amid concerns

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to be higher when the interval between doses was within the four to 12 weeks range…reports Asian Lite News

https://www.youtube.com/watch?v=uDMHC59PCnQ

The World Health Organization (WHO) has decided that potential benefits of the Oxford-AstraZeneca Covid-19 vaccine outweigh known and potential risks, amid concerns over its efficacy against the virus variant found in South Africa.

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) panel on Wednesday said the two-dose AstraZeneca vaccine efficacy tended to be higher when the interval between doses was within the four to 12 weeks range, reports Xinhua news agency.

It also added that although preliminary analyses based on a small sample size in South Africa indicate a marked reduction in vaccine effectiveness against mild and moderate disease, it did not allow a specific assessment of vaccine efficacy against severe Covid-19.

As indirect evidence is compatible with protection against severe Covid-19, the situation remains to be demonstrated in ongoing clinical trials and post-implementation evaluations.

In view of this, WHO currently recommends the use of the AstraZeneca vaccine even if the variants are present in a country.

Countries should conduct a benefit-risk assessment according to the local epidemiological situation, including the extent of circulating virus variants.

“We have made a recommendation that even if there is a reduction in the possibility of this vaccine having a full impact in its protection capacity, especially against severe disease, there is no reason not to recommend its use even in countries that have circulation of the variant,” said SAGE chair Alejandro Cravioto at a briefing on Wednesday.

Meanwhile, SAGE cautioned that as there are currently no efficacy or safety data for children or adolescents below the age of 18 years, vaccination of individuals below 18 years of age is not recommended until such data are available.

South Africa said recently that the rollout of the AstraZeneca vaccine in the country would be temporarily put on hold until more “clinically efficacy information” of the vaccine against new Covid-19 variant becomes available.

The decision came after a study showed that the AstraZeneca vaccine was less effective against the new variant found in South Africa.

Also read:2.3 mn voters register for upcoming Palestinian polls

Previous Story

2.3 mn voters register for upcoming Palestinian polls

Next Story

IS threats spike again: UN

Latest from -Top News

India wins unopposed seat on UNHRC

India last served on the HRC in 2024, completing a second consecutive term….reports Asian Lite News India has been elected unopposed to the UN Human Rights Council (HRC) for the seventh time,

Relief Rolls In, Restrictions Remain in Gaza

Israeli official noted an Israeli statement saying it would limit the number of aid truckloads entering the Gaza Strip to 300 daily…reports Asian Lite News Relief operations in Gaza have intensified since

‘A Day to Rejoice’

In its statement, British Friends of Israel saluted the courage and resilience of the hostages and expressed deep sorrow for those who did not survive captivity After 737 days of anguish, the

UK to Lead Gaza Rebuild

PM announces an additional £20 million aid package aimed at providing essential water, sanitation and hygiene services to tens of thousands of people Prime Minister Keir Starmer attended the signing ceremony of

UK to host summit on Gaza recovery plan

The three-day conference, beginning Monday afternoon, will take place at Wilton Park, the Foreign Office’s policy forum based in West Sussex The UK will host an international summit on the recovery and
Go toTop